Download full-text PDF |
Source |
---|
J Med Case Rep
September 2023
Department of Radiology, Saint Laurent-du-Maronil Hospital, Avenue Paul Castaing, 97320, Saint-Laurent du Maroni, French Guiana.
Background: We report a case of prenatal coronavirus disease 2019, which evolved 6 days after birth into severe pneumonia with signs of multiple organ failure, in a mother with asymptomatic coronavirus disease 2019.
Case Presentation: At minute 11 of life, our patient from Afro-Caribbean had polypnea with mild signs of struggle; Silverman's index was scored at three. Chest radiography showed bilateral opacities consistent with respiratory distress syndrome.
J Surg Res
September 2023
Department of Surgery, Guthrie Robert Packer Hospital, Sayre, Pennsylvania.
Introduction: The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to implementing strict social distancing mandates nationwide. This study evaluates the trauma trends during the pandemic at a rural level II trauma center in Pennsylvania.
Methods: A retrospective review of all trauma registries between 2018 and 2021 was performed overall and on a 6-month basis.
Stroke
January 2022
Neurosurgery (R.W.R., A.A.D., J.E.V., C.J.S., A.B.P.), Massachusetts General Hospital, Harvard Medical School, Boston.
J Stroke Cerebrovasc Dis
October 2021
Department of Radiology, Division of Neuroradiology, Massachusetts General Hospital, Boston, MA, US.
Objectives: Luminal-based imaging have identified different risk factors for extracranial and intracranial atherosclerosis (ICAS), but these techniques are known to underestimate the true extent of the disease. High-resolution (HR) vessel wall imaging (VWI) has recently gained recognition as a valuable tool in the assessment of ICAS. The aim of this study is to determine the association between cardiovascular risk factors and specific intracranial vessel segment involvement using HR-VWI.
View Article and Find Full Text PDFPain Med
March 2018
Pfizer Inc., New York, New York.
Objective: To evaluate the effect of baseline characteristics on the treatment response to pregabalin in fibromyalgia (FM) patients with depression.
Design: Post hoc analysis from a randomized, double-blind, placebo-controlled, two-way crossover study of pregabalin (300 or 450 mg/day, twice daily).
Subjects: A total of 193 FM patients taking an antidepressant for comorbid depression.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!